Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

BIT/PHN stock hub

BIT/PHN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BIT/PHNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

743M

Borsa Italiana

Market data

Live price

Current market quote for this ticker.

Current price

BIT/PHN

In the news

Latest news · BIT/PHN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E30.5

P25 13P50 15.3P75 18.4

Trailing P/E37.2

P25 14.4P50 21.2P75 24.6

ROE29.9

P25 3.1P50 8.5P75 13.3

ROIC30.4

P25 5.3P50 8.5P75 15.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BIT/PHN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

234

Groups with data

Currency

EUR

Showing 234 of 234 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Italy
Country code	IT
Employees	128
Employees Change	10%
Employees Change Percent	8.47
Enterprise value	EUR 732.9M
Exchange	Borsa Italiana
Financial currency	EUR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	IT0005274094
Last refreshed	2026-05-10
Market cap	EUR 743M
Price	EUR 77.6
Price currency	EUR
Rev Per Employee	1,032,468.75x
Sector	Healthcare
Sic	2834
Symbol	bit/PHN
Website	https://www.pharmanutra.it

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.69%
EV Earnings	36.64x
EV/EBIT	25.18x
EV/EBITDA	22.69x
EV/FCF	44.61x
EV/Sales	5.55x
FCF yield	2.21%
Forward P/E	30.54x
P/B ratio	10.43x
P/E ratio	37.2x
P/S ratio	5.62x
PE Ratio10 Y	30.12x
PE Ratio3 Y	34.01x
PE Ratio5 Y	36.72x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	22.02%
EBITDA Margin	24.08%
FCF margin	12.43%
Gross margin	50.54%
Gross Profit	EUR 66.8M
Gross Profit Growth	12.74%
Gross Profit Growth Q	9.7%
Gross Profit Growth3 Y	16.8%
Gross Profit Growth5 Y	20.29%
Net Income	EUR 20M
Net Income Growth	20.44%
Net Income Growth Q	74.32%
Net Income Growth Quarters	3%
Net Income Growth Years	2%
Net Income Growth3 Y	9.95%
Net Income Growth5 Y	7.29%
Pretax Margin	22.84%
Profit Margin	15.14%
Profit Per Employee	EUR 156,266
Profitable Years	11
ROA	14.99
Roa5y	15.76
ROCE	30.9
ROE	29.87
Roe5y	29.45
ROIC	30.42
Roic5y	42.27

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	45.96%
Cagr3y	16.88%
Cagr5y	17.51%
Div CAGR3	14.47%
Div CAGR5	12.36%
EPS Growth	20.63
EPS Growth Q	74.49
EPS Growth Quarters	3
EPS Growth Years	2
EPS Growth3 Y	10.27
EPS Growth5 Y	7.5
FCF Growth	1.59%
FCF Growth Q	131.5%
FCF Growth5 Y	10.18%
OCF Growth	-4.22%
OCF Growth Q	80.92%
OCF Growth3 Y	3.85%
OCF Growth5 Y	10.64%
Revenue Growth	13.78x
Revenue Growth Q	15.55x
Revenue Growth Quarters	7x
Revenue Growth Years	10x
Revenue Growth3 Y	16.74x
Revenue Growth5 Y	18.41x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.09
Assets	EUR 125.2M
Cash	EUR 30.6M
Current Assets	EUR 72.9M
Current Liabilities	EUR 31M
Debt	EUR 20.5M
Debt EBITDA	EUR 0.64
Debt Equity	EUR 0.29
Debt FCF	EUR 1.25
Equity	EUR 71.2M
Interest Coverage	43.9
Liabilities	EUR 54M
Long Term Assets	EUR 52.3M
Long Term Liabilities	EUR 23M
Net Cash	EUR 10.1M
Net Cash By Market Cap	EUR 1.36
Net Cash Growth	114.91%
Net Debt EBITDA	EUR -0.32
Net Debt Equity	EUR -0.14
Net Debt FCF	EUR -0.61
Tangible Book Value	EUR 49.9M
Tangible Book Value Per Share	EUR 5.21
WACC	4.75

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.35
Inventory Turnover	8.28
Net Working Capital	EUR 16.3M
Quick ratio	1.86
Working Capital	EUR 41.9M
Working Capital Turnover	EUR 3.32

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.16%
Dividend Growth	20%
Dividend Growth Years	5%
Dividend per share	EUR 1.2
Dividend Years	9
Dividend Yield	1.55%
Ex Div Date	2026-05-04
Last Dividend	EUR 1.2
Payout Frequency	Annual
Payout Ratio	47.95%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	45.93%
200-day SMA	57.51
3Y total return	59.68%
50-day SMA	74.89
50-day SMA vs 200-day SMA	50over200
5Y total return	124.04%
All Time High	83.3
All Time High Change	-6.84%
All Time High Date	2026-04-17
All Time Low	12
All Time Low Change	546.67%
All Time Low Date	2017-10-02
ATR	2.33
Beta	0.1
Beta1y	0.72
Beta2y	0.69
Ch YTD	42.91
High	79.4
High52	83.3
High52 Date	2026-04-17
High52ch	-6.84%
Low	77.2
Low52	38.75
Low52 Date	2025-10-01
Low52ch	100.26%
Ma50ch	3.61%
Price vs 200-day SMA	34.93%
RSI	49.27
RSI Monthly	66.24
RSI Weekly	69.6
Sharpe ratio	1.13x
Sortino ratio	2.64
Total Return	1.71%
Tr YTD	45.12
Tr1m	0.64%
Tr1w	-2.63%
Tr3m	26.69%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 29.1M
Operating Income Growth	6.38
Operating Income Growth Q	13.86
Operating Income Growth3 Y	8.05
Operating Income Growth5 Y	15.49
Operating margin	22.02

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,273,520%
Net Borrowing	-3,755,000
Shares Insiders	65.81%
Shares Institutions	11.72%
Shares Out	9,575,183
Shares Qo Q	-0.89%
Shares Yo Y	-0.16%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 16.4M
Average Volume	12,814.65x
Bv Per Share	7.44
CAPEX	EUR -3.1M
Ch1m	-0.89
Ch1w	-2.63
Ch1y	43.7
Ch3m	24.76
Ch3y	49.52
Ch5y	107.5
Ch6m	74.78
Change	0.13%
Change From Open	-1.77
Close	77.5
Days Gap	1.94
Depreciation Amortization	2,717,000
Dollar Volume	1,489,842.4
Earnings Date	2026-05-14
EBIT	EUR 29.1M
EBITDA	EUR 31.8M
EPS	EUR 2.09
F Score	5
FCF	EUR 16.4M
FCF EV Yield	2.24x
FCF Per Share	EUR 1.72
Financing CF	-13,118,000
Fiscal Year End	December
Founded	2,000
Goodwill	17,560,000
Graham Number	18.68819
Graham Upside	-75.92
Income Tax	EUR 10.3M
Investing CF	-3,363,000
Is Primary Listing	1
Last Earnings Date	2025-11-06
Last Report Date	2025-12-31
Lynch Fair Value	EUR 15.2
Lynch Upside	-80.41
Ma150	61.58
Ma150ch	26.01%
Ma20	79.55
Ma20ch	-2.45%
Net CF	3,081,000
Next Earnings Date	2026-05-14
Open	79
P FCF Ratio	45.23
P OCF Ratio	37.98
Payment Date	2026-05-06
Position In Range	18.18
Ppne	24,132,000
Price Date	2026-05-08
Price EBITDA	EUR 23.35
Ptbv Ratio	14.9
Relative Volume	1.52x
Revenue	132,156,000x
Tax By Revenue	7.77x
Tax Rate	34.03%
Tr6m	77.48%
Volume	19,199
Z Score	7.75

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BIT/PHN dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.5%

$1.20 annual per share

Payout ratio

+48.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+12.4%

5 consecutive years of growth

Total shareholder yield

+1.7%

Next ex-dividend date: 2026-05-04

Performance

BIT/PHN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BIT/PHN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+11.7%

Share of float held by funds and institutions

Insider ownership

+65.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.2%

Negative means the company is buying back shares.

Technical

BIT/PHN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.3

Neutral momentum band

Price vs 200-day MA

+34.9%

50/200-day relationship not available

Beta (5Y)

0.10

Less volatile than the market

Sharpe ratio

1.13

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BIT/PHN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bit/PHN stock rating?

bit/PHN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bit/PHN analysis?

The full report lives at /stocks/bit/PHN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bit/PHN?

The latest report frames bit/PHN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bit/PHN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.